CBDNewsBreaks – MCTC Holdings, Inc. (MCTC) Announces New Infusion System to Enable Easy Production of Clean-Label Hemp Extract and CBD Single-Serving Coffee and Beverage PODS

January 27, 2020 11:32:42

MCTC Holdings (OTC: MCTC), a company developing unique hemp infusion technologies and cannabinoid delivery systems, today announced a new system to enable coffee and other beverage companies to easily produce clean-label hemp extract and cannabidiol (CBD) single-serving coffee and beverage pods. The product offering, named Hemp You Can Feel(TM) Coffee Infusions, is based on two recently filed patents and will allow coffee manufacturers to produce coffee pods with precisely measured amounts of hemp extracts, CBD, or other cannabinoids and avoid the complexities of CBD infusions and potency testing. “We are now offering single-serving coffee manufacturers a superior method to infuse products with CBD and other cannabinoids,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “It is so revolutionary, we have filed two patents; one on the underlying powderization technology and another on the use of solid and powdered dosing forms for cannabinoids in single-serving beverage pods. With our new products, manufacturers are able to precisely dose each pod with the exact amount of active ingredient desired. The technology is easily customizable to suit the particular requirements of the application. With the product offering, even the smallest of single-serving pod manufacturers will be able to easily transform ordinary low margin products into products that are high margin and very profitable.”

To view the full press release, visit http://cnw.fm/pMw9Q

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.